AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Production ends on FluShield, Pnu-Imune vaccines.
2003 JAN 8 - (NewsRx.com & NewsRx.net) -- Wyeth (WYE) announced that it is ceasing production of two of its vaccine products - FluShield, an injectable influenza virus vaccine and Pnu-Imune, an injectable polysaccharide pneumococcal vaccine for adults.
Adequate supplies of injectable flu vaccine are now available in the U.S. as a result of recent capacity increases provided by other manufacturers.
In addition, Wyeth has chosen to pursue new flu immunization technologies - specifically through its partnership with MedImmune to develop and market FluMist, an intranasal influenza vaccine. ...
- Production ends on FluShield, Pnu-Imune vaccines.(Brief Article)
- Newspaper article from: Virus Weekly January 7, 2003 700+ words
2003 JAN 7 - (NewsRx.com & NewsRx.net) -- Wyeth (WYE) announced that it is ceasing production of two of its vaccine products - FluShield, an injectable influenza virus vaccine and Pnu-Imune, an injectable polysaccharide pneumococcal vaccine for adults. Adequate supplies of injectable flu
- Lock to food-borne pathogen pathway may be key to vaccine.
- Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...Medicine and the U.S. Department of Agriculture-Agricultural Research Service. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
- Antibodies against Neisseria meningitidis isolated.
- Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...Neisseria, Bacteriology, Vaccine Development, Immunotherapy, and Meningitis Vaccine. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
- Vaccines against prion diseases may be in sight.
- Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...Neurology, Neuroscience, Vaccine Development, Proteomics, and Emerging Pathogens. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
- Batch of rabies vaccine found ineffective.
- Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...Immunotherapy, Vaccine Development, Vaccine Efficacy, Virology, and Vectors and Zoonoses. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
- Study shows low risk of vaccinia transfer after immunization.
- Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...hopefully now we've got a lot of contemporary data to help answer it," said Talbot. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
- RANK-L gene improves the T cell immune response to infectious agents.
- Newspaper article from: Vaccine Weekly February 11, 2004 700+ words
...of DNA Vaccine, Vaccine Development, Vaccine Efficacy, Proteomics, and Virology. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
- Vaccines for cervical cancer reviewed.
- Newspaper article from: Vaccine Weekly February 11, 2004 700+ words
...Oncology, Immunotherapy, Virology, Vaccine Development, and Women's Health. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
Source: HighBeam Research, Production ends on FluShield, Pnu-Imune vaccines.